UnknownNCT02338479
Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies
Studying Acute lymphoblastic leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Center for International Blood and Marrow Transplant Research
- Principal Investigator
- Christine Duncan, MDDana-Farber Cancer Institute
- Enrollment
- 340 enrolled
- Eligibility
- 22 years · All sexes
- Timeline
- 2015 – 2023
Study locations (30)
- Mayo Clinic, Scottsdale, Arizona, United States
- University of Arizona Medical Center, Tucson, Arizona, United States
- Children's Hospital of Los Angeles, Los Angeles, California, United States
- UCLA Center for Health Sciences, Los Angeles, California, United States
- Children's Hospital & Research Center - Oakland, Oakland, California, United States
- University of California San Francisco Medical Center, San Francisco, California, United States
- University of Colorado, Aurora, Colorado, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- All Children's Hospital, St. Petersburg, Florida, United States
- Children's Healthcare of Atlanta, Atlanta, Georgia, United States
- Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- Indiana University Hospital/Riley Hospital for Children, Indianapolis, Indiana, United States
- Dana Farber Cancer Institute - Pediatrics, Boston, Massachusetts, United States
- University of Michigan, Ann Arbor, Michigan, United States
- The Children's Mercy Hospitals and Clinics, Kansas City, Missouri, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Pediatric Blood and Marrow Transplant Consortium · National Marrow Donor Program
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02338479 on ClinicalTrials.govOther trials for Acute lymphoblastic leukemia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05621291A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...National Cancer Institute (NCI)
- ENROLLING BY INVITATIONNCT07511959Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative DentistryWroclaw Medical University
- RECRUITINGPHASE2NCT06738368Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic LeukemiaUniversity of Washington
- RECRUITINGNANCT07191119Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic LeukemiaSt. Jude Children's Research Hospital
- RECRUITINGNANCT07177183Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning FailureUniversity Hospital Ostrava
- RECRUITINGPHASE2NCT07275762Y-4 to Treat the Postherpetic NeuralgiaNeurodawn Pharmaceutical Co., Ltd.
- ENROLLING BY INVITATIONNCT07515430The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic LeukemiaSun Yat-sen University
- RECRUITINGNANCT07201974Virtual Reality for Post-Stroke Gait RehabilitationMcGill University